Fig. 7

Overview of study protocol including time-points of imaging, clearing and pathology staining: hematoxylin and eosin (H&E) staining and, immunohistochemistry (IHC) staining (epidermal growth factor receptor, cytokeratin AE1/3 and programmed death-ligand 1).